In Monday’s weekly digest, we flagged early signs that accreditation reform was emerging in procurement language and late-stage buying conversations across higher education. What was initially easy to dismiss as policy noise is now showing up in real deals, changing how institutions evaluate risk, involve stakeholders, and ultimately decide whether they can move forward.

This deep dive builds on that signal and explains why deals that feel approved are stalling, why objections are emerging late in the process, and what vendors need to change now to avoid being quietly filtered out in 2026 buying cycles.

Pipelines are still there. Projects are still funded. Buyers are still engaged. In many cases, functional teams have already selected a preferred vendor. And yet, deals that would historically have closed are now stretching by months, shrinking in scope, or going quiet after verbal alignment.

The reason is not macro uncertainty. It is not ARPA digestion. And it is not indecision.

What has changed is when institutional risk shows up in the buying process.

Over the past six to nine months, accreditation and administrative capability concerns have moved from background assumptions to explicit gating factors. Institutions are increasingly treating vendor selection as something that must be defensible to accreditors, auditors, and federal reviewers not just usable by the department that initiated the purchase.

That shift matters because those stakeholders do not sit at the table early.

In many deals, the academic unit, IT team, or functional owner still runs the initial evaluation. Product fit, implementation feasibility, and budget alignment look acceptable. The vendor believes the deal is progressing normally.

The stall happens later, when the decision has to survive institutional scrutiny.

At that point, new questions appear. Not about features or outcomes, but about exposure.

These questions are not hypothetical. They are being asked now because recent federal and accreditation-linked regulatory changes have raised the cost of getting this wrong. Institutions that fail administrative capability reviews or mismanage third-party risk face real consequences, including funding disruption and Title IV exposure. As a result, precautionary behavior has replaced discretionary buying.

Vendors often assume that if accreditation were truly a blocker, it would surface early or appear explicitly in the RFP.

In practice, the opposite is happening.

Accreditation language is increasingly embedded in procurement criteria, risk assessments, and contract approvals rather than highlighted in early discovery. It shows up as scored requirements around governance, evidence standards, and institutional accountability. It also brings new reviewers into the process legal, audit, institutional research, compliance officers who were not involved when the solution was first evaluated.

By the time those stakeholders engage, the question is no longer whether the solution works.

It is whether the institution can defend choosing it.

That is why vendors are hearing objections late, after months of progress. And that is why those objections are often framed as requests for more time, more review, or more documentation rather than outright rejection.

The institution is not saying no. It is deciding whether it can say yes safely.

Many vendors describe current deals as delayed rather than lost. That framing is accurate, but misleading if interpreted as temporary.